Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Mills, Katie
SCH Asthma, NCT04845932: Finding Correlations Between Asthma Exacerbation, Physiological Measurements and Environmental Factors	Recruiting	N/A	20	US		North Carolina State University, University of North Carolina, Chapel Hill	Asthma	12/24	12/24
Attack Asthma, NCT04748055: Examining Changes in Nasal IL-1 During Acute Asthma Exacerbation in Adolescents	Completed	N/A	40	US		University of North Carolina, Chapel Hill, National Heart, Lung, and Blood Institute (NHLBI)	Asthma	02/24	02/24
RAPID, NCT04287621: Registry of Asthma Patients Initiating DUPIXENT®	Active, not recruiting	N/A	718	Europe, Canada, Japan, US	DUPIXENT®, dupilumab, REGN668, SAR231893	Regeneron Pharmaceuticals, Sanofi	Asthma	07/26	07/26